NCT03179813

Brief Summary

The investigators set out to develop a clinical trial in order to test the topical use of hydrocortisone as a intraoperative irrigant solution. As this route of administration as well as being low cost and not add new steps to the surgical procedure, can contribute to an improved quality of life in the postoperative period of patients undergoing extraction of third molars.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

May 29, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 7, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

March 7, 2018

Status Verified

November 1, 2017

Enrollment Period

8 months

First QC Date

May 29, 2017

Last Update Submit

March 6, 2018

Conditions

Keywords

hydrocortisonethird molaroral surgerypostoperative painedema

Outcome Measures

Primary Outcomes (1)

  • Edema

    Change in edema measures

    From the preoperative moment to the second postoperative day

Secondary Outcomes (2)

  • Pain

    Up to 2 days (amount of analgesic medication intake form the immediate postoperative moment to the second postoperative day)

  • Pain

    Up to 2 days (from the immediate postoperative moment to the second postoperative day)

Study Arms (2)

Hydrocortisone group

EXPERIMENTAL

Intraoperative topical use of hydrocortisone as a irrigation solution in third molar surgery.

Procedure: Hydrocortisone

Control Group

PLACEBO COMPARATOR

Intraoperative irrigation with saline solution.

Procedure: Control

Interventions

During the third molar extraction the hydrocortisone solution will be used in the test group

Hydrocortisone group
ControlPROCEDURE

During the third molar extraction the saline solution will be used in the control group

Control Group

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Health patients of any sex, with symmetric bilateral bone-impacted mandibular third molars requiring surgical removal, and with no history of allergy to the drugs used in this study.

You may not qualify if:

  • Use of analgesic or anti-inflammatory drugs 24 hours before the surgery.
  • Pregnant or breastfeeding patients,
  • Use of other drugs beyond of that one's prescribed by the researchers;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vitor Pereira Rodrigues

São Paulo, São Paulo, 04105000, Brazil

Location

Related Publications (7)

  • Ngeow WC, Lim D. Do Corticosteroids Still Have a Role in the Management of Third Molar Surgery? Adv Ther. 2016 Jul;33(7):1105-39. doi: 10.1007/s12325-016-0357-y. Epub 2016 Jun 10.

    PMID: 27287853BACKGROUND
  • Herrera-Briones FJ, Prados Sanchez E, Reyes Botella C, Vallecillo Capilla M. Update on the use of corticosteroids in third molar surgery: systematic review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Nov;116(5):e342-51. doi: 10.1016/j.oooo.2012.02.027. Epub 2012 Aug 17.

    PMID: 22902498BACKGROUND
  • Grossi GB, Maiorana C, Garramone RA, Borgonovo A, Beretta M, Farronato D, Santoro F. Effect of submucosal injection of dexamethasone on postoperative discomfort after third molar surgery: a prospective study. J Oral Maxillofac Surg. 2007 Nov;65(11):2218-26. doi: 10.1016/j.joms.2006.11.036.

    PMID: 17954317BACKGROUND
  • Ceccheti MM, Negrato GV, Peres MP, Deboni MC, Naclerio-Homem Mda G. Analgesic and adjuvant anesthetic effect of submucosal tramadol after mandibular third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Mar;117(3):e249-54. doi: 10.1016/j.oooo.2012.05.015. Epub 2012 Sep 12.

    PMID: 22981094BACKGROUND
  • Pourdanesh F, Khayampour A, Jamilian A. Therapeutic effects of local application of dexamethasone during bilateral sagittal split ramus osteotomy surgery. J Oral Maxillofac Surg. 2014 Jul;72(7):1391-4. doi: 10.1016/j.joms.2013.12.025. Epub 2014 Jan 15.

    PMID: 24576440BACKGROUND
  • Mahmoud Hashemi H, Mohammadi F, Hasheminasab M, Mahmoud Hashemi A, Zahraei S, Mahmoud Hashemi T. Effect of low-concentration povidone iodine on postoperative complications after third molar surgery: a pilot split-mouth study. J Oral Maxillofac Surg. 2015 Jan;73(1):18-21. doi: 10.1016/j.joms.2014.06.454. Epub 2014 Jul 5.

    PMID: 25249172BACKGROUND
  • UStun Y, Erdogan O, Esen E, Karsli ED. Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Nov;96(5):535-9. doi: 10.1016/S1079210403004645.

    PMID: 14600686BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeEdema

Interventions

Hydrocortisone

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

PregnenedionesPregnenesPregnanesSteroidsFused-Ring CompoundsPolycyclic Compounds11-HydroxycorticosteroidsHydroxycorticosteroidsAdrenal Cortex HormonesHormonesHormones, Hormone Substitutes, and Hormone Antagonists17-Hydroxycorticosteroids

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate

Study Record Dates

First Submitted

May 29, 2017

First Posted

June 7, 2017

Study Start

May 1, 2017

Primary Completion

January 3, 2018

Study Completion

March 1, 2018

Last Updated

March 7, 2018

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations